A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

CompletedOBSERVATIONAL
Enrollment

3,111

Participants

Timeline

Start Date

November 26, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Non-small-cell Lung Cancer (NSCLC)
Trial Locations (32)

Unknown

Research Site, Buenos Aires

Research Site, Rosario

Research Site, Santiago

Research Site, Córdoba

Research Site, Medellín

Research Site, Santiago de Cali

Research Site, Santo Domingo

Research Site, Anand

Research Site, Bangalore

Research Site, Calicut

Research Site, Chennai

Research Site, Mohali

Research Site, Mumbai

Research Site, Nashik

Research Site, New Delhi

Research Site, Odissa

Research Site, Srinagar

Research Site, West Bengal

Research Site, Guadalajara

Research Site, Mexico City

Research Site, Toluca

Research Site, Lima

Research Site, Kaohsiung City

Research Site, Taichung

Research Site, Tainan City

Research Site, Taipei

Research Site, Taoyuan District

Research Site, Bangkoknoi

Research Site, Dusit

Research Site, Pathumwan

Research Site, Ratchathewi

Research Site, Montevideo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY